SVD PHARMA: what changed
Two fiscal years side by side, explained: what moved most in the balance sheet and the result, why the result rose or fell, and where the money went.
SVD PHARMA
Largest movements
- Receivables within one year +€12,769
up €12,769 (+33.6%), from €37,960 to €50,729
of which Trade receivables: +€24,027
- Debts after one year -€35,425
down €35,425 (-19.9%), from €178,138 to €142,712
- Other debts +€30,860
up €30,860 (+34.3%), from €89,888 to €120,749
- Reserves +€23,288
up €23,288 (+7.2%), from €325,314 to €348,602
- Accrued charges and deferred income -€7,951
down €7,951 (-100.0%), from €7,951 to €0
- Gross operating margin -€16,976
down €16,976 (-31.1%), from €54,596 to €37,619
- Financial charges -€3,252
down €3,252 (-29.6%), from €10,977 to €7,725
- Taxes -€2,802
down €2,802 (-31.1%), from €9,020 to €6,218
From the 2024 result to the 2025 result
Each bar is the change in one income-statement line, as its effect on the result: higher costs pull it down, higher income lifts it.
Cash bridge derived
Derived from the 2024 and 2025 balance sheets and the 2025 result: not a filed cash-flow statement. It shows where the money came from and went.
Every line side by side
| Line | Code | 2024 | 2025 | Change | % |
|---|---|---|---|---|---|
| Total assets | 20/58 | €669,462 | €682,392 | +€12,930 | +1.9% |
| Fixed assets | 21/28 | €630,615 | €630,615 | = | 0.0% |
| Financial fixed assets | 28 | €630,615 | €630,615 | = | 0.0% |
| Current assets | 29/58 | €38,847 | €51,777 | +€12,930 | +33.3% |
| Amounts receivable within one year | 40/41 | €37,960 | €50,729 | +€12,769 | +33.6% |
| Trade receivables | 40 | €16,935 | €40,962 | +€24,027 | +141.9% |
| Other amounts receivable | 41 | €21,025 | €9,767 | -€11,258 | -53.5% |
| Cash at bank and in hand | 54/58 | €0 | - | = | |
| Deferred charges and accrued income | 490/1 | €888 | €1,048 | +€161 | +18.1% |
| Total equity and liabilities | 10/49 | €669,462 | €682,392 | +€12,930 | +1.9% |
| Equity | 10/15 | €343,914 | €367,202 | +€23,288 | +6.8% |
| Contributions | 10/11 | €18,600 | €18,600 | = | 0.0% |
| Reserves | 13 | €325,314 | €348,602 | +€23,288 | +7.2% |
| Distributable reserves | 133 | €325,314 | €348,602 | +€23,288 | +7.2% |
| Amounts payable | 17/49 | €325,548 | €315,190 | -€10,358 | -3.2% |
| Amounts payable after more than one year | 17 | €178,138 | €142,712 | -€35,425 | -19.9% |
| Financial debts | 170/4 | €178,138 | €142,712 | -€35,425 | -19.9% |
| Amounts payable within one year | 42/48 | €139,459 | €172,478 | +€33,019 | +23.7% |
| Current portion of amounts payable after more than one year | 42 | €39,839 | €38,631 | -€1,207 | -3.0% |
| Financial debts | 43 | €692 | €507 | -€185 | -26.7% |
| Credit institutions | 430/8 | €692 | €507 | -€185 | -26.7% |
| Trade debts | 44 | €0 | €1,430 | +€1,430 | |
| Suppliers | 440/4 | €0 | €1,430 | +€1,430 | |
| Taxes, remuneration and social security | 45 | €9,040 | €11,160 | +€2,120 | +23.5% |
| Taxes | 450/3 | €9,040 | €11,160 | +€2,120 | +23.5% |
| Remuneration and social security | 454/9 | €0 | - | = | |
| Other amounts payable | 47/48 | €89,888 | €120,749 | +€30,860 | +34.3% |
| Accrued charges and deferred income | 492/3 | €7,951 | €0 | -€7,951 | -100.0% |
| Other operating charges | 640/8 | €351 | €388 | +€36 | +10.4% |
| Gross operating margin | 9900 | €54,596 | €37,619 | -€16,976 | -31.1% |
| Operating profit (loss) | 9901 | €54,244 | €37,232 | -€17,013 | -31.4% |
| Financial income | 75/76B | €0 | - | = | |
| Recurring financial income | 75 | €0 | - | = | |
| Financial charges | 65/66B | €10,977 | €7,725 | -€3,252 | -29.6% |
| Recurring financial charges | 65 | €10,977 | €7,725 | -€3,252 | -29.6% |
| Profit (loss) for the period before taxes | 9903 | €43,267 | €29,506 | -€13,761 | -31.8% |
| Income taxes | 67/77 | €9,020 | €6,218 | -€2,802 | -31.1% |
| Profit (loss) for the period | 9904 | €34,247 | €23,288 | -€10,959 | -32.0% |
| Profit (loss) for the period to be appropriated | 9905 | €34,247 | €23,288 | -€10,959 | -32.0% |
Source: filed annual accounts (NBB), fiscal years ended 31 December 2024 and 31 December 2025. Colour: green is a favourable move for that line, red an unfavourable one. Prepared on 4 October 2026 via checked.be.